Sedation Strategy and Cognitive Outcome After Critical Illness in Early Childhood

Completed

Conditions studied: Intellectual Disability, Perceptual Disorders, Memory Disorders

In brief

The purpose of this study is to determine the relationships between sedative exposure during pediatric critical illness and long-term neurocognitive outcomes. We will test for drug- and dose-dependent relationships between sedative exposure and neurocognitive outcomes along the early developmental spectrum and will control for baseline and environmental factors, as well as the severity and course of illness. Hypotheses: 1. Greater exposure to benzodiazepines and/or ketamine will be associated with lower IQ even when controlling for severity of illness, hospital course, and baseline factors. In addition, benzodiazepines and/or ketamine will negatively affect other aspects of neurocognitive function. 2. Younger children exposed to benzodiazepines and/or ketamine will have worse neurocognitive outcomes than older children with similar sedative exposure and severity of illness.

Key facts

Study ID
NCT02225041
Run by
University of Pennsylvania
People needed
360
Starts
2014-08-01
Expected to finish
2018-12-01
Last updated by the study team
2019-06-18

Who can join

Age: 3 and older, up to 13. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.